Kolexia
Chanez Brice
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
101 Activités
470 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Tumeurs du pancréas Métastase tumorale Adénocarcinome Tumeurs du cerveau Tumeurs du sein Tumeurs du poumon Tumeurs du rein

Industries

Amgen
8 collaboration(s)
Dernière en 2023
Servier
8 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2020
CanceroDigest
2 collaboration(s)
Dernière en 2022

Dernières activités

PACsign: Pilot Study of Personalized First-line Chemotherapy Choice for Patients With Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
Essai Clinique (Institut Curie)   29 janvier 2024
Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
Frontiers in oncology   08 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
La prise en charge du cancer du pancréas - Brice CHANEZ
Youtube @ Institut Paoli-Calmettes   16 novembre 2023
Assessment of biological effect of nab-paclitaxel combined with gemcitabine, using contrast enhanced ultrasonography and elastography, in advanced pancreatic ductal carcinoma: A single-center pilot study.
Endoscopic ultrasound   31 octobre 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French Center.
Journal of gastrointestinal and liver diseases : JGLD   28 septembre 2023
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten): Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Essai Clinique (Centre Léon-Bérard)   31 août 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
Journal for immunotherapy of cancer   07 août 2023
Application of the RECIST Thresholds to the Carbohydrate Antigen 19-9 Variation after FOLFIRINOX Induction for Borderline Pancreatic Adenocarcinoma
Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.   01 janvier 2023
A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma.
Gastroenterology   07 décembre 2022